Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy

scientific article published on 6 November 2013

Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/21691401.2013.845569
P698PubMed publication ID24195582
P5875ResearchGate publication ID258334753

P2093author name stringSwati Gupta
Sachin Yadav
P2860cites workRapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysQ25939005
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewQ29617388
Folate-mediated delivery of macromolecular anticancer therapeutic agentsQ34804841
Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomesQ36713632
EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancerQ39560008
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro.Q40633595
Preparation, Characterization and Evaluation of Docetaxel-loaded, Folate-conjugated PEG-liposomesQ42866610
Aerosolized liposome-based delivery of amphotericin B to alveolar macrophagesQ43539445
Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasisQ44226161
Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug deliveryQ44585942
Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liverQ46990174
Rapid separation of low molecular weight solutes from liposomes without dilutionQ47315153
Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis.Q51766744
Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting.Q51797993
Docetaxel: a new active agent in the therapy of metastatic breast cancer.Q53853229
P433issue2
P304page(s)93-102
P577publication date2013-11-06
P1433published inArtificial cells, nanomedicine, and biotechnologyQ27724536
P1476titleDevelopment and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy
P478volume43

Reverse relations

cites work (P2860)
Q48206992Comparison of Dialysis- and Solvatofluorochromism-Based Methods to Determine Drug Release Rates from Polymer Nanoassemblies.
Q49154861Folate-PEG-decorated docetaxel lipid nanoemulsion for improved antitumor activity
Q38694253NanoMIL-100(Fe) containing docetaxel for breast cancer therapy
Q51711370Redox poly(ethylene glycol)-b-poly(L-lactide) micelles containing diselenide bonds for effective drug delivery.
Q96837357The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells
Q51133850Wound healing effects of nanoemulsion containing clove essential oil.
Q46305754pH-sensitive metal-phenolic network capsules for targeted photodynamic therapy against cancer cells

Search more.